1. FGFR4 and EZH2 inhibitors synergistically induce hepatocellular carcinoma apoptosis via repressing YAP signaling
   Yiqi Yang et al, 2023, Journal of Experimental & Clinical Cancer Research CrossRef
2. Dysregulated Genes and Signaling Pathways in the Formation and Rupture of Intracranial Aneurysm
   Munish Kumar et al, 2023, Translational Stroke Research CrossRef
3. Regulatory effects of statins on Akt signaling for prevention of cancers
   Fatemeh Sadat Hosseini et al, 2024, Cellular Signalling CrossRef
4. A comprehensive review of the PTEN/PI3K/Akt axis in multiple myeloma: From molecular interactions to potential therapeutic targets
   Mina Alimohammadi et al, 2024, Pathology - Research and Practice CrossRef
5. Extracellular signal-Regulated Kinase 5 (ERK5) is required for the Yes-associated protein (YAP) co-transcriptional activity
   Francesca Ippolito et al, 2023, Cell Death & Disease CrossRef
6. Unraveling Connective Tissue Growth Factor as a Therapeutic Target and Assessing Kahweol as a Potential Drug Candidate in Triple-Negative Breast Cancer Treatment
   Jeong Hee Lee et al, 2023, International Journal of Molecular Sciences CrossRef
7. Targeting the Hippo pathway to prevent radioresistance brain metastases from the lung (Review)
   Jasmine Taylor et al, 2024, International Journal of Oncology CrossRef
8. Atp8a1 deletion increases the proliferative activity of hematopoietic stem cells by impairing PTEN function
   Li Zheng et al, 2023, Cellular Oncology CrossRef
9. New emerging targets in osteosarcoma therapy: PTEN and PI3K/Akt crosstalk in carcinogenesis
   Mehrdokht Sadrkhanloo et al, 2023, Pathology - Research and Practice CrossRef